Back to trial detailsIntake questionnaire
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Applying to NorthShore University Health System - Evanston Hospital · Evanston, Illinois
Answer a few short questions to share with the research team.
0 of 4 answered